Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Onychomycosis | 10 | 1999 | 50 | 1.230 |
Why?
|
Alopecia | 5 | 2019 | 416 | 0.750 |
Why?
|
Skin Aging | 6 | 1997 | 140 | 0.630 |
Why?
|
Rosacea | 6 | 2024 | 60 | 0.620 |
Why?
|
Cosmetic Techniques | 1 | 2019 | 149 | 0.550 |
Why?
|
Dermatology | 6 | 2019 | 905 | 0.500 |
Why?
|
Doxepin | 4 | 1999 | 16 | 0.460 |
Why?
|
Photography | 5 | 1997 | 537 | 0.460 |
Why?
|
Antifungal Agents | 11 | 2000 | 761 | 0.430 |
Why?
|
Skin Care | 4 | 2009 | 55 | 0.430 |
Why?
|
Dermatitis, Atopic | 7 | 2003 | 737 | 0.390 |
Why?
|
Dermatologic Agents | 9 | 1998 | 313 | 0.370 |
Why?
|
Skin Diseases | 7 | 1998 | 1085 | 0.360 |
Why?
|
Antipruritics | 3 | 1999 | 31 | 0.340 |
Why?
|
Facial Dermatoses | 4 | 1997 | 87 | 0.320 |
Why?
|
Acne Vulgaris | 6 | 2004 | 352 | 0.310 |
Why?
|
Erythema | 5 | 2009 | 261 | 0.290 |
Why?
|
Hair Follicle | 3 | 2018 | 219 | 0.270 |
Why?
|
Hand Dermatoses | 8 | 1999 | 61 | 0.270 |
Why?
|
Tinea | 2 | 1996 | 13 | 0.260 |
Why?
|
Health Personnel | 1 | 2019 | 3385 | 0.240 |
Why?
|
Alopecia Areata | 3 | 2018 | 130 | 0.240 |
Why?
|
Oxyhemoglobins | 2 | 1997 | 213 | 0.240 |
Why?
|
Quality of Life | 7 | 2019 | 13490 | 0.240 |
Why?
|
Psoriasis | 5 | 2020 | 926 | 0.240 |
Why?
|
Fluconazole | 4 | 2000 | 156 | 0.230 |
Why?
|
Keratolytic Agents | 3 | 2001 | 34 | 0.220 |
Why?
|
Keratosis | 2 | 1995 | 81 | 0.220 |
Why?
|
Double-Blind Method | 21 | 2024 | 12465 | 0.210 |
Why?
|
Anti-Inflammatory Agents | 5 | 2003 | 1805 | 0.210 |
Why?
|
Foot Dermatoses | 6 | 1999 | 46 | 0.200 |
Why?
|
Finasteride | 2 | 1999 | 86 | 0.190 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 1999 | 112 | 0.190 |
Why?
|
Tacrolimus | 2 | 2003 | 750 | 0.180 |
Why?
|
Administration, Cutaneous | 8 | 1999 | 716 | 0.180 |
Why?
|
Androgens | 2 | 2016 | 1281 | 0.180 |
Why?
|
Eczema | 3 | 2003 | 245 | 0.170 |
Why?
|
Delphi Technique | 1 | 2024 | 891 | 0.170 |
Why?
|
Medical Staff Privileges | 1 | 1998 | 13 | 0.160 |
Why?
|
Hyperpigmentation | 2 | 1997 | 116 | 0.160 |
Why?
|
Administration, Topical | 7 | 2003 | 703 | 0.150 |
Why?
|
Credentialing | 1 | 1998 | 114 | 0.150 |
Why?
|
Carcinoma, Basal Cell | 2 | 1995 | 565 | 0.150 |
Why?
|
Dermatitis, Contact | 2 | 1995 | 134 | 0.150 |
Why?
|
Naphthalenes | 2 | 2000 | 198 | 0.150 |
Why?
|
Drug Eruptions | 3 | 1998 | 335 | 0.140 |
Why?
|
Post-Concussion Syndrome | 1 | 2020 | 257 | 0.140 |
Why?
|
Dermatitis, Irritant | 1 | 1997 | 17 | 0.140 |
Why?
|
Pharmaceutical Vehicles | 5 | 1998 | 56 | 0.140 |
Why?
|
Tretinoin | 2 | 1997 | 524 | 0.140 |
Why?
|
Skin Diseases, Infectious | 1 | 1997 | 75 | 0.130 |
Why?
|
Scalp | 1 | 1999 | 391 | 0.130 |
Why?
|
Glycolates | 1 | 1996 | 41 | 0.130 |
Why?
|
Metronidazole | 1 | 1998 | 236 | 0.130 |
Why?
|
Tinea Versicolor | 1 | 1996 | 9 | 0.130 |
Why?
|
Tinea Capitis | 1 | 1996 | 16 | 0.130 |
Why?
|
Chemexfoliation | 1 | 1995 | 11 | 0.130 |
Why?
|
Vitiligo | 1 | 1996 | 97 | 0.120 |
Why?
|
Lactates | 1 | 1996 | 401 | 0.120 |
Why?
|
Herpes Genitalis | 1 | 1996 | 149 | 0.120 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 1996 | 75 | 0.120 |
Why?
|
Sunlight | 1 | 1996 | 337 | 0.120 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 1995 | 186 | 0.120 |
Why?
|
Ultraviolet Rays | 2 | 1997 | 1103 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3212 | 0.110 |
Why?
|
Humans | 79 | 2024 | 768166 | 0.110 |
Why?
|
Immunosuppressive Agents | 3 | 2003 | 4206 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 1995 | 278 | 0.110 |
Why?
|
Nevus | 1 | 1995 | 205 | 0.100 |
Why?
|
Dermatomyositis | 1 | 1996 | 259 | 0.100 |
Why?
|
Drug Approval | 1 | 2020 | 821 | 0.100 |
Why?
|
Mohs Surgery | 1 | 1995 | 217 | 0.100 |
Why?
|
Scleroderma, Systemic | 1 | 1996 | 346 | 0.100 |
Why?
|
Isotretinoin | 3 | 2001 | 134 | 0.100 |
Why?
|
Hamartoma | 1 | 1995 | 236 | 0.100 |
Why?
|
Ointments | 3 | 2003 | 58 | 0.100 |
Why?
|
Pruritus | 2 | 1998 | 379 | 0.100 |
Why?
|
Anesthesia, Conduction | 1 | 1995 | 263 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 1999 | 3728 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1995 | 664 | 0.100 |
Why?
|
Tumor Virus Infections | 1 | 1995 | 437 | 0.100 |
Why?
|
Light | 1 | 1997 | 1355 | 0.100 |
Why?
|
PUVA Therapy | 3 | 1996 | 101 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2016 | 1194 | 0.090 |
Why?
|
Travel | 1 | 1997 | 805 | 0.090 |
Why?
|
Ambulatory Surgical Procedures | 1 | 1995 | 452 | 0.090 |
Why?
|
Biological Products | 1 | 2020 | 948 | 0.090 |
Why?
|
Skin Neoplasms | 3 | 1995 | 5863 | 0.090 |
Why?
|
Nevus, Pigmented | 1 | 1992 | 222 | 0.080 |
Why?
|
Lipectomy | 1 | 1991 | 114 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1596 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 1995 | 939 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8054 | 0.080 |
Why?
|
Papillomaviridae | 1 | 1995 | 1140 | 0.080 |
Why?
|
Ultraviolet Therapy | 2 | 2001 | 82 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 1995 | 985 | 0.070 |
Why?
|
Adult | 29 | 2024 | 223646 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2016 | 874 | 0.070 |
Why?
|
Radiation Injuries | 1 | 1995 | 1198 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1885 | 0.070 |
Why?
|
Skin | 4 | 2001 | 4503 | 0.070 |
Why?
|
Clindamycin | 2 | 1997 | 138 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2257 | 0.070 |
Why?
|
Retinoids | 2 | 1998 | 99 | 0.060 |
Why?
|
United States | 11 | 2020 | 73039 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2536 | 0.060 |
Why?
|
Melanoma | 2 | 1995 | 5706 | 0.060 |
Why?
|
Pigmentation Disorders | 1 | 1985 | 105 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3929 | 0.060 |
Why?
|
Evaluation Studies as Topic | 2 | 1997 | 1627 | 0.060 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3488 | 0.060 |
Why?
|
Combined Modality Therapy | 5 | 2001 | 8542 | 0.060 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2004 | 21 | 0.060 |
Why?
|
Dosage Forms | 3 | 2001 | 56 | 0.060 |
Why?
|
Placebos | 2 | 2020 | 1667 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4055 | 0.060 |
Why?
|
Glucocorticoids | 4 | 2003 | 2167 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10399 | 0.060 |
Why?
|
Fluorescence | 2 | 1997 | 756 | 0.060 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2005 | 225 | 0.060 |
Why?
|
Middle Aged | 20 | 2024 | 223492 | 0.050 |
Why?
|
Melphalan | 1 | 2005 | 421 | 0.050 |
Why?
|
Clinical Competence | 1 | 2019 | 4858 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2016 | 3445 | 0.050 |
Why?
|
Academies and Institutes | 2 | 1995 | 326 | 0.050 |
Why?
|
Male | 25 | 2024 | 364719 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 1995 | 1640 | 0.050 |
Why?
|
Administration, Oral | 4 | 2000 | 4030 | 0.050 |
Why?
|
Drug Administration Schedule | 6 | 2001 | 4860 | 0.050 |
Why?
|
Treatment Outcome | 12 | 2024 | 65371 | 0.050 |
Why?
|
Recurrence | 4 | 2018 | 8509 | 0.050 |
Why?
|
Insurance, Physician Services | 1 | 2002 | 23 | 0.050 |
Why?
|
Dihydrotestosterone | 2 | 1999 | 195 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2005 | 631 | 0.050 |
Why?
|
Arthrodermataceae | 2 | 1998 | 7 | 0.050 |
Why?
|
Acitretin | 1 | 2001 | 16 | 0.050 |
Why?
|
Female | 25 | 2024 | 397192 | 0.050 |
Why?
|
Androstane-3,17-diol | 1 | 1999 | 20 | 0.040 |
Why?
|
Aged | 15 | 2020 | 171504 | 0.040 |
Why?
|
Dermatomycoses | 1 | 2000 | 45 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1995 | 4058 | 0.040 |
Why?
|
Nails | 2 | 1998 | 298 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36743 | 0.040 |
Why?
|
Rest | 1 | 2024 | 948 | 0.040 |
Why?
|
Nematode Infections | 1 | 1998 | 19 | 0.040 |
Why?
|
Dinitrochlorobenzene | 1 | 1978 | 18 | 0.040 |
Why?
|
Triamcinolone Acetonide | 1 | 1999 | 105 | 0.040 |
Why?
|
Nitrobenzenes | 1 | 1978 | 64 | 0.040 |
Why?
|
Physical Examination | 2 | 1995 | 1263 | 0.040 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2018 | 94 | 0.040 |
Why?
|
Epidermophyton | 1 | 1997 | 4 | 0.040 |
Why?
|
Nicotinic Acids | 1 | 1998 | 33 | 0.040 |
Why?
|
France | 1 | 1999 | 497 | 0.040 |
Why?
|
Medicare | 1 | 1996 | 6809 | 0.040 |
Why?
|
Trichophyton | 1 | 1997 | 21 | 0.040 |
Why?
|
Soil | 1 | 1998 | 120 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15948 | 0.040 |
Why?
|
Shoes | 1 | 1998 | 91 | 0.040 |
Why?
|
Interleukin-15 | 1 | 2018 | 186 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 1998 | 2430 | 0.040 |
Why?
|
Haemophilus ducreyi | 1 | 1997 | 4 | 0.040 |
Why?
|
Life Style | 1 | 2009 | 3932 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 1996 | 13014 | 0.040 |
Why?
|
Belize | 1 | 1997 | 15 | 0.040 |
Why?
|
Ectoparasitic Infestations | 1 | 1997 | 12 | 0.040 |
Why?
|
Larva Migrans | 1 | 1997 | 7 | 0.040 |
Why?
|
Tick Infestations | 1 | 1997 | 9 | 0.040 |
Why?
|
Rickettsia Infections | 1 | 1997 | 8 | 0.040 |
Why?
|
Myiasis | 1 | 1997 | 14 | 0.040 |
Why?
|
Sea Anemones | 1 | 1997 | 15 | 0.040 |
Why?
|
Italy | 1 | 1999 | 856 | 0.040 |
Why?
|
Germany | 1 | 1999 | 883 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 1998 | 175 | 0.030 |
Why?
|
Haemophilus Infections | 1 | 1997 | 94 | 0.030 |
Why?
|
Anisotropy | 1 | 2020 | 1292 | 0.030 |
Why?
|
Adolescent | 10 | 2001 | 89169 | 0.030 |
Why?
|
Specialty Boards | 1 | 1998 | 235 | 0.030 |
Why?
|
Absenteeism | 1 | 1998 | 247 | 0.030 |
Why?
|
Toes | 1 | 1997 | 209 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 1996 | 59 | 0.030 |
Why?
|
Tinea Pedis | 1 | 1996 | 4 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1998 | 10760 | 0.030 |
Why?
|
Thailand | 1 | 1997 | 288 | 0.030 |
Why?
|
Neurodermatitis | 1 | 1995 | 8 | 0.030 |
Why?
|
Anthralin | 1 | 1995 | 5 | 0.030 |
Why?
|
Hydroxides | 1 | 1995 | 46 | 0.030 |
Why?
|
Tars | 1 | 1995 | 20 | 0.030 |
Why?
|
Potassium Compounds | 1 | 1995 | 42 | 0.030 |
Why?
|
Protoporphyrins | 1 | 1996 | 168 | 0.030 |
Why?
|
Scleroderma, Localized | 1 | 1996 | 85 | 0.030 |
Why?
|
Acyclovir | 1 | 1996 | 267 | 0.030 |
Why?
|
Cost of Illness | 3 | 2003 | 1951 | 0.030 |
Why?
|
Pathology | 1 | 1998 | 270 | 0.030 |
Why?
|
Hair Diseases | 1 | 1996 | 72 | 0.030 |
Why?
|
Sunscreening Agents | 1 | 1996 | 139 | 0.030 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 1997 | 137 | 0.030 |
Why?
|
Accreditation | 1 | 1998 | 476 | 0.030 |
Why?
|
Certification | 1 | 1998 | 420 | 0.030 |
Why?
|
Spectrophotometry, Infrared | 1 | 1995 | 116 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 1995 | 2337 | 0.030 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1995 | 124 | 0.030 |
Why?
|
Drug Interactions | 2 | 2000 | 1419 | 0.030 |
Why?
|
Electrosurgery | 1 | 1995 | 53 | 0.030 |
Why?
|
Melanins | 1 | 1997 | 292 | 0.030 |
Why?
|
Patch Tests | 1 | 1995 | 57 | 0.030 |
Why?
|
Skin Pigmentation | 1 | 1997 | 280 | 0.030 |
Why?
|
Sleep Stages | 2 | 1999 | 706 | 0.030 |
Why?
|
Telephone | 1 | 1998 | 630 | 0.030 |
Why?
|
Cyclosporine | 1 | 1997 | 777 | 0.030 |
Why?
|
Child | 7 | 2001 | 80917 | 0.030 |
Why?
|
Keratinocytes | 1 | 2018 | 876 | 0.030 |
Why?
|
Single-Blind Method | 1 | 1997 | 1587 | 0.030 |
Why?
|
Esthetics | 1 | 1995 | 328 | 0.030 |
Why?
|
Office Visits | 1 | 1998 | 595 | 0.030 |
Why?
|
Dengue | 1 | 1997 | 258 | 0.030 |
Why?
|
Demography | 1 | 1998 | 1641 | 0.030 |
Why?
|
Drug Combinations | 1 | 1999 | 2089 | 0.030 |
Why?
|
Cicatrix | 1 | 2019 | 798 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 1985 | 3049 | 0.030 |
Why?
|
Brazil | 1 | 1997 | 1250 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 1998 | 39348 | 0.030 |
Why?
|
Self Concept | 1 | 1998 | 1043 | 0.020 |
Why?
|
Epinephrine | 1 | 1995 | 794 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2018 | 1361 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1673 | 0.020 |
Why?
|
Abdominal Pain | 1 | 1997 | 1070 | 0.020 |
Why?
|
Skin Transplantation | 1 | 1996 | 1096 | 0.020 |
Why?
|
Tablets | 2 | 2001 | 149 | 0.020 |
Why?
|
Managed Care Programs | 1 | 1996 | 939 | 0.020 |
Why?
|
Medical History Taking | 1 | 1995 | 779 | 0.020 |
Why?
|
Interferons | 1 | 1995 | 720 | 0.020 |
Why?
|
Lactic Acid | 1 | 1996 | 1140 | 0.020 |
Why?
|
Diarrhea | 1 | 1997 | 1320 | 0.020 |
Why?
|
Biological Availability | 2 | 2001 | 389 | 0.020 |
Why?
|
Hemoglobins | 1 | 1997 | 1531 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 1998 | 1434 | 0.020 |
Why?
|
Time Factors | 4 | 1998 | 40218 | 0.020 |
Why?
|
Cholecalciferol | 1 | 1995 | 557 | 0.020 |
Why?
|
Patient Care Planning | 1 | 1995 | 905 | 0.020 |
Why?
|
Photochemotherapy | 1 | 1996 | 830 | 0.020 |
Why?
|
Faculty, Medical | 1 | 1998 | 1226 | 0.020 |
Why?
|
Research | 1 | 1998 | 1979 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3160 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 1999 | 20227 | 0.020 |
Why?
|
Drug Costs | 1 | 1998 | 1195 | 0.020 |
Why?
|
Anesthetics | 1 | 1995 | 525 | 0.020 |
Why?
|
Rhinophyma | 1 | 2009 | 7 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2420 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 1886 | 0.020 |
Why?
|
Remission Induction | 1 | 1995 | 2410 | 0.020 |
Why?
|
Cryosurgery | 1 | 1995 | 479 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3117 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5315 | 0.020 |
Why?
|
Health Expenditures | 1 | 2002 | 2389 | 0.020 |
Why?
|
Telangiectasis | 1 | 2009 | 78 | 0.020 |
Why?
|
Attitude to Health | 1 | 1998 | 2025 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2211 | 0.020 |
Why?
|
Testosterone | 1 | 1999 | 2491 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 1995 | 1005 | 0.020 |
Why?
|
Medicaid | 1 | 2002 | 2840 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 1997 | 7477 | 0.020 |
Why?
|
Comorbidity | 2 | 2019 | 10590 | 0.020 |
Why?
|
Sex Factors | 2 | 1998 | 10632 | 0.020 |
Why?
|
Psychotherapy | 1 | 1996 | 1654 | 0.020 |
Why?
|
Forecasting | 1 | 1996 | 2945 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2018 | 2747 | 0.020 |
Why?
|
Health Care Reform | 1 | 1996 | 1256 | 0.020 |
Why?
|
General Surgery | 1 | 1998 | 1720 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2005 | 5196 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2005 | 5717 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 1995 | 923 | 0.020 |
Why?
|
Pain | 2 | 1999 | 5100 | 0.020 |
Why?
|
Chronic Disease | 2 | 2001 | 9384 | 0.020 |
Why?
|
Nail Diseases | 1 | 1985 | 54 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7852 | 0.020 |
Why?
|
Curriculum | 1 | 1998 | 3782 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 1999 | 59629 | 0.020 |
Why?
|
Reoperation | 1 | 1995 | 4329 | 0.010 |
Why?
|
Leukapheresis | 1 | 2005 | 150 | 0.010 |
Why?
|
Postoperative Care | 1 | 1991 | 1480 | 0.010 |
Why?
|
Wound Healing | 1 | 1995 | 2809 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2001 | 7454 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6211 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10266 | 0.010 |
Why?
|
Antiviral Agents | 1 | 1996 | 3073 | 0.010 |
Why?
|
Eye Diseases | 1 | 2009 | 660 | 0.010 |
Why?
|
Minocycline | 1 | 2004 | 170 | 0.010 |
Why?
|
Laser Therapy | 1 | 2009 | 1107 | 0.010 |
Why?
|
Xerophthalmia | 1 | 2001 | 12 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14729 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2004 | 6316 | 0.010 |
Why?
|
Retreatment | 1 | 2003 | 598 | 0.010 |
Why?
|
Child, Preschool | 2 | 2001 | 42669 | 0.010 |
Why?
|
Itraconazole | 1 | 2000 | 43 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2005 | 2120 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2001 | 526 | 0.010 |
Why?
|
Health Care Costs | 2 | 2003 | 3239 | 0.010 |
Why?
|
Neutropenia | 1 | 2005 | 892 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54926 | 0.010 |
Why?
|
Markov Chains | 1 | 2003 | 979 | 0.010 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2003 | 388 | 0.010 |
Why?
|
Parasite Egg Count | 1 | 1998 | 29 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18349 | 0.010 |
Why?
|
Triamcinolone | 1 | 1999 | 68 | 0.010 |
Why?
|
Transcription Factors | 1 | 2018 | 12168 | 0.010 |
Why?
|
Societies, Medical | 1 | 1991 | 3968 | 0.010 |
Why?
|
Internship and Residency | 1 | 1998 | 5953 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2005 | 952 | 0.010 |
Why?
|
Incidence | 1 | 1996 | 21538 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 1999 | 26379 | 0.010 |
Why?
|
Mucous Membrane | 1 | 2001 | 659 | 0.010 |
Why?
|
Infant | 2 | 1998 | 36535 | 0.010 |
Why?
|
Age Factors | 3 | 2005 | 18412 | 0.010 |
Why?
|
Inflammation | 1 | 1997 | 10873 | 0.010 |
Why?
|
Vietnam | 1 | 1998 | 415 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1985 | 2709 | 0.010 |
Why?
|
Health Services | 1 | 2003 | 755 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27360 | 0.010 |
Why?
|
Gels | 1 | 1998 | 423 | 0.010 |
Why?
|
Hair | 1 | 1999 | 508 | 0.010 |
Why?
|
Animals | 2 | 2018 | 169246 | 0.010 |
Why?
|
Affect | 1 | 2001 | 1495 | 0.010 |
Why?
|
Headache | 1 | 2001 | 1263 | 0.010 |
Why?
|
Prevalence | 2 | 2002 | 15869 | 0.010 |
Why?
|
Safety | 1 | 1998 | 1159 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2002 | 81762 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2002 | 1668 | 0.010 |
Why?
|
Hydrocortisone | 1 | 1999 | 1841 | 0.010 |
Why?
|
Odds Ratio | 1 | 2003 | 9669 | 0.010 |
Why?
|
Lipids | 1 | 2001 | 3343 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2003 | 5536 | 0.010 |
Why?
|
Risk Factors | 1 | 1995 | 74944 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1991 | 15832 | 0.000 |
Why?
|
Contraception | 1 | 1988 | 362 | 0.000 |
Why?
|
Informed Consent | 1 | 1988 | 1010 | 0.000 |
Why?
|
Depression | 1 | 2001 | 8230 | 0.000 |
Why?
|
Prognosis | 1 | 2001 | 30010 | 0.000 |
Why?
|
Pregnancy | 1 | 1988 | 30256 | 0.000 |
Why?
|
Concepts
(338)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_